UBS O'Connor’s Verona Pharma VRNA Stock Holding History

UBS O'Connor’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-25,000	Closed	-$100K	–	468
2024 Q4	$100K	Hold	25,000	–	–	﹤0.01%	349
2024 Q3	$25.6K	Sell	25,000 -15,000	-38%	-$369K	﹤0.01%	439
2024 Q2	$5K	Buy	+40,000	New	+$584K	﹤0.01%	519

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

UBS O'Connor's VRNA Position: Q4 2025 in Review

UBS O'Connor sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 4,283,462 shares — an estimated $457M sold.

UBS O'Connor first reported a position in VRNA in Q3 2022 and held it in 9 quarters. The position peaked at $457M in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

UBS O'Connor reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
UBS O'Connor sold 4,283,462 Verona Pharma shares in Q4 2025, an estimated $457M.
UBS O'Connor first reported a position in Verona Pharma in Q3 2022 and held it in 9 quarters.
UBS O'Connor's Verona Pharma position peaked at $457M in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on UBS O'Connor's 13F filing for Q4 2025, filed 13 Feb 2026.